Ketamine or ECT? What have we learned from the KetECT and ELEKT-D trials?

Ekstrand, JoakimLund University,Lunds universitet,Enheten för psykiatrisk neuromodulering (PNU),Forskargrupper vid Lunds universitet,Psychiatric Neuromodulation Unit (PNU),Lund University Research Groups (författare)

Two recent clinical trials, KetECT and ELEKT-D, compared the effectiveness of ketamine and electroconvulsive therapy (ECT) for major depressive disorder. Notably, these trials reported marked differences in ECT's clinical outcomes of, with remission rates of 63% for KetECT and a strikingly lower rate of 22% for ELEKT-D, while the remission rates for ketamine were 46% and 38%, respectively. Considering that the primary objective of both trials was to compare the standard treatment (ECT) with an experimental intervention (ketamine), it is crucial to highlight the pronounced disparities in ECT's clinical outcomes. This article offers a comprehensive comparison of these trials while also exploring how patient characteristics, treatment protocols, and study designs may contribute to such pronounced outcome discrepancies. These differences highlight the heterogeneous nature of depression and underscore the need for personalized treatments. These studies also provide valuable insights into identifying the most suitable candidates for ketamine and ECT.

Takamiya, AkihiroKU Leuven, Leuven Brain Institute, Department of Neurosciences, Neuropsychiatry, Leuven, Belgium; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan (författare)
Nordenskjöld, Axel,1977-Örebro University,Örebro universitet,Institutionen för medicinska vetenskaper,University Health Care Research Centre, Faculty of Medicine and Health, Örebro University, Örebro, Sweden(Swepub:oru)alnd (författare)
Kirov, GeorgeCentre for Neuropsychiatric Genetics & Genomics, Cardiff University School of Medicine Division of Psychological Medicine and Clinical Neuroscience, Cardiff, UK (författare)
Sienaert, PascalDepartment of Neurosciences, University Psychiatric Center KU Leuven, Research Group Psychiatry, Academic Center for ECT and Neuromodulation (AcCENT), KU Leuven, Leuven, Belgium,Catholic University of Leuven (författare)
Kellner, CharlesDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (författare)
Movahed Rad, PouyaLund University,Lunds universitet,Enheten för psykiatrisk neuromodulering (PNU),Forskargrupper vid Lunds universitet,Psychiatric Neuromodulation Unit (PNU),Lund University Research Groups(Swepub:lu)kfar-pmo (författare)
Enheten för psykiatrisk neuromodulering (PNU)Forskargrupper vid Lunds universitet (creator_code:org_t)

Ingår i:International Journal of Neuropsychopharmacology: Oxford University Press27:11461-14571469-5111

Av författaren/redakt...: Ekstrand, Joakim; Takamiya, Akihir ...; Nordenskjöld, Ax ...; Kirov, George; Sienaert, Pascal; Kellner, Charles; visa fler...; Movahed Rad, Pou ...; visa färre...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Psykiatri

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.